Compare ResMed Inc. (RMD) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Southern Copper Corp — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.73B), while Southern Copper Corp trades at $195.5 (market cap $176.69B). The key difference: Southern Copper Corp is far larger — about 5.6× ResMed Inc.'s market cap, and Southern Copper Corp pays the higher dividend (2.1%). Which is the better fit depends on your goals.
| RMD | SCCO | |
|---|---|---|
Market Cap | $31.73B | $176.69B |
Sector | Health | Basic Materials |
52-Week High | $283.28 | $219.70 |
52-Week Low | $182.82 | $102.10 |
Enterprise Value | $31.08B | $177.98B |
Dividend Yield | 1.2% | 2.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $221.05, down 3.2% on the day, with a bearish technical signal and key support at $218. The company reported strong Q4 2026 results, beating EPS estimates at $2.95, and maintains robust profitability with a 26.94% net income margin. Revenue growth remains solid, reaching $5.15B in 2025, though weak 2027 sales guidance has pressured the stock. A dividend of $0.66 is scheduled for payment in September 2026.
Outlook is mixed: strong fundamentals and a consensus price target of $235.70 suggest upside, but bearish technicals and investor lawsuits pose near-term risks. The stock offers value with a P/E of 21.19, yet competitive and regulatory challenges require monitoring for sustained growth.
Southern Copper (SCCO) trades at $208.56, up 4.93% in the last 24 hours, with a bullish technical signal from moving averages and strong support near $205. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $1.99 exceeding expectations, and demonstrates high profitability with a net margin of 35.87% and ROE of 50.07%. Revenue growth is accelerating, reaching $13.42B in 2025, supported by rising copper prices and a $20.5B investment plan for production expansion.
The outlook for SCCO is positive due to strong copper demand from AI infrastructure and trade policy shifts, but risks include premium valuations (P/E of 31.29) and lower H1 2026 copper output. Analyst sentiment is mixed with a consensus price target of $154.58, below the current price, indicating caution despite institutional buying interest from firms like BlackRock and Bank of New York Mellon.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
